Table 4.
Comparing migraine headache duration between the two groups at baseline and each visit
| L-carnitine group | Propranolol group | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| No headache | < 1 hour | 1-2 hours | 2-6 hours | > 6hours | No headache | < 1 hour | 1-2 hours | 2-6 hours | > 6hours | |
| Baseline | 0 | 2(7.7%) | 10(38.5%) | 10(38.5%) | 4(15.4%) | 0 | 7(25%) | 10(35.7%) | 7(25%) | 4(14.3%) |
| After 2 weeks | 1(3.8%) | 12(46.2%) | 6(23.1%) | 6(23.1%) | 1(3.8%) | 5(17.9%) | 11(39.3%) | 6(21.4%) | 4(14.3%) | 2(7.1%) |
| After 4 weeks | 8(30.8%) | 9(34.6%) | 6(23.1%) | 3(11.5%) | 0 | 9(32.1%) | 11(39.3%) | 5(17.9%) | 3(10.7%) | 0 |
| After 12 weeks | 8(30.8%) | 8(30.8%) | 8(30.8%) | 2(7.7%) | 0 | 7(25%) | 15(53.6%) | 4(14.3%) | 2(7.1%) | 0 |
Data is presented as N(%). Both l-carnitine and propranolol significantly decreased headache duration in the two groups (p < 0.001). The difference in headache duration between the two groups at each visit was not statistically significant (p > 0.1).